Finance

Lists
1VKTX:BIT
Viking Therapeutics Inc
€27.60
-0.54%
(-0.15) 1D
Sep 11, 5:35:07 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1VKTX...
Open
€27.60
High
€27.60
Low
€27.60
Mkt. cap
3.77B
Avg. vol.
185.00
Volume
438.00
52-wk high
€37.00
52-wk low
€18.98
No. of employees
65
Open
€27.60
High
€27.60
Low
€27.60
Mkt. cap
3.77B
Avg. vol.
185.00
Volume
438.00
52-wk high
€37.00
52-wk low
€18.98
No. of employees
65
News stories
From web sources and news partners
About Viking Therapeutics Inc
CEOBrian Lian
Employees65
Founded2012
Headquarters-
SectorBiotechnology
Websitevikingtherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
89.95M
153.46M
150.15M
115.75M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.61M
11.28M
13.98M
16.84M
Operating expense
98.56M
164.74M
164.12M
132.60M
Total operating expenses
98.56M
164.74M
164.12M
132.60M
Operating income
-98.56M
-164.74M
-164.12M
-132.60M
Other non operating income
-
-
-
-
EBT including unusual items
-90.79M
-157.66M
-158.32M
-128.02M
EBT excluding unusual items
-90.80M
-157.70M
-158.32M
-128.05M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-90.79M
-157.66M
-158.32M
-128.02M
Net profit margin
-
-
-
-
Earnings per share
-0.81
-1.38
-1.37
-1.10
Interest and investment income
7.77M
7.04M
5.80M
4.54M
Interest expense
-8.00K
-
-
-
Net interest expenses
7.76M
7.04M
5.80M
4.54M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps